CV Sciences (CVSI) Selling, General & Administrative (2011 - 2026)
CV Sciences (CVSI) Selling, General & Administrative (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.73 Mn |
| Mar 31, 2026 | 1.86 Mn |
| Dec 31, 2025 | -2.74 Mn |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Mar 31, 2025 | 960,000.00 |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 740,000.00 |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | -3.41 Mn |
| Sep 30, 2023 | 2.24 Mn |
| Jun 30, 2023 | 2.76 Mn |
| Mar 31, 2023 | 2.16 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 2.41 Mn |
| Jun 30, 2022 | 3.48 Mn |
| Mar 31, 2022 | 2.55 Mn |
| Dec 31, 2021 | 10.09 Mn |
| Sep 30, 2021 | 4.93 Mn |